Public Employees Retirement System of Ohio Purchases New Position in Tempus AI, Inc. $TEM

Public Employees Retirement System of Ohio purchased a new stake in Tempus AI, Inc. (NASDAQ:TEMFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 43,126 shares of the company’s stock, valued at approximately $2,740,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. First Horizon Advisors Inc. increased its stake in shares of Tempus AI by 12.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company’s stock valued at $89,000 after purchasing an additional 208 shares in the last quarter. Farther Finance Advisors LLC increased its stake in shares of Tempus AI by 59.9% in the 2nd quarter. Farther Finance Advisors LLC now owns 884 shares of the company’s stock valued at $56,000 after purchasing an additional 331 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in shares of Tempus AI by 100.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock valued at $39,000 after purchasing an additional 400 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Tempus AI by 10.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,594 shares of the company’s stock valued at $268,000 after purchasing an additional 515 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of Tempus AI by 6.1% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 9,681 shares of the company’s stock valued at $590,000 after purchasing an additional 560 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Trading Up 9.0%

TEM opened at $87.99 on Thursday. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $97.79. The stock has a market capitalization of $15.29 billion, a PE ratio of -73.94 and a beta of 4.89. The business’s 50 day moving average price is $73.92 and its 200 day moving average price is $62.59. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.

Tempus AI (NASDAQ:TEMGet Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million for the quarter, compared to analysts’ expectations of $296.84 million. During the same period in the prior year, the firm posted ($6.86) earnings per share. The firm’s quarterly revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Transactions at Tempus AI

In related news, CFO James William Rogers sold 7,528 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer directly owned 138,473 shares in the company, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The shares were sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the transaction, the chief executive officer owned 9,141,032 shares in the company, valued at $699,837,409.92. This represents a 3.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 933,662 shares of company stock valued at $67,909,393 in the last ninety days. 26.27% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

TEM has been the subject of several research reports. Guggenheim boosted their price objective on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. Piper Sandler reiterated a “neutral” rating on shares of Tempus AI in a research note on Friday, August 8th. Morgan Stanley boosted their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 12th. Bank of America boosted their price objective on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 25th. Finally, BTIG Research boosted their price objective on Tempus AI from $75.00 to $85.00 and gave the stock a “buy” rating in a research note on Wednesday, August 20th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $71.83.

Get Our Latest Analysis on Tempus AI

About Tempus AI

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read More

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEMFree Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.